Research brief · Metabolic
Cagrilintide
Long-acting amylin analogue for combination incretin research.
Class
Long-acting amylin analogue
Half-life
~7 days
Studied in
Combination incretin studies, food intake models.
What it is
Cagrilintide is a long-acting amylin analogue engineered for weekly exposure, frequently studied in combination with semaglutide to probe amylin–incretin synergy.
Mechanism studied
Activates amylin/calcitonin receptors.
Research notes
- Commonly paired with semaglutide in dual-mechanism studies.
Before sourcing any material
- Confirm a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity).
- Check the stated peptide content per vial, not just the gross vial mass.
- Plan reconstitution volumes first so the vial size matches your protocol.
- Verify what is lawful in your jurisdiction — these are in-vitro research reagents, not medicines.